EKSPATEL, OOO, Moscow

Economic indicators

Net profit (RAS) of EKSPATEL, OOO grew over 2024 by 13.54% to 914.00 thousand RUB from 805.00 thousand RUB over 2023, the company informed.

Revenue decreased in the accounting period by 25.62% to 5.26 million RUB from 7.07 million RUB in 2023; sales profit fell by 42.37% to 1.49 million RUB from 2.59 million RUB.

Net profit (RAS) of EKSPATEL, OOO grew over 2023 2.29 times to 805.00 thousand RUB from 352.00 thousand RUB over 2022, the company informed.

Revenue increased in the accounting period by 45.69% to 7.07 million RUB from 4.85 million RUB over 2022; sales profit went up 1.95 times to 2.59 million RUB from 1.33 million RUB.

Net profit (RAS) of EKSPATEL, OOO grew over 2022 2.30 times to 352.00 thousand RUB from 153.00 thousand RUB over 2021, the company informed.

Revenue increased in the accounting period 3.02 times to 4.85 million RUB from 1.61 million RUB over 2021; sales profit went up 2.21 times to 1.33 million RUB from 602.00 thousand RUB.

Net profit (RAS) of EKSPATEL, OOO grew over 2021 3.33 times to 153.00 thousand RUB from 46.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period 1.61 times to 1.61 million RUB from 1.00 million RUB over 2020; sales profit went up 6.54 times to 602.00 thousand RUB from 92.00 thousand RUB.

Net profit (RAS) of EKSPATEL, OOO grew over 2020 7.67 times to 46.00 thousand RUB from 6.00 thousand RUB over 2019, the company informed.

Sales profit made up 92.00 thousand RUB compared to sales loss of 77.00 thousand RUB.

Companies in the region

• AKVALAYN
• RENUAR
• BIOPROFMED
• LITSAR
• MEDTEKHSERVIS PREDPRIYATIE